Platelet Membrane Biomimetic Manganese Carbonate Nanoparticles Promote Breast Cancer Stem Cell Clearance for Sensitized Radiotherapy
Yi Jiang,Xiaoming Liao,Wei Tang,Chunyu Huang,You Pan,Shipeng Ning
DOI: https://doi.org/10.2147/ijn.s450018
IF: 7.033
2024-02-21
International Journal of Nanomedicine
Abstract:Yi Jiang, 1, &ast Xiaoming Liao, 1, &ast Wei Tang, 2 Chunyu Huang, 3 You Pan, 2 Shipeng Ning 2 1 Department of Breast Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530000, People's Republic of China; 2 Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, People's Republic of China; 3 Key Laboratory of Artificial Micro- and Nano-Structures of Ministry of Education, School of Physics and Technology, Wuhan University, Wuhan, 430072, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shipeng Ning, Email Introduction: The presence of cancer stem cells (CSCs) significantly limits the therapeutic efficacy of radiotherapy (RT). Efficient elimination of potential CSCs is crucial for enhancing the effectiveness of RT. Methods: In this study, we developed a biomimetic hybrid nano-system (PMC) composed of MnCO 3 as the inner core and platelet membrane (PM) as the outer shell. By exploiting the specific recognition properties of membrane surface proteins, PMC enables precise targeting of CSCs. Sonodynamic therapy (SDT) was employed using manganese carbonate nanoparticles (MnCO 3 NPs), which generate abundant reactive oxygen species (ROS) upon ultrasound (US) irradiation, thereby impairing CSC self-renewal capacity and eradicating CSCs. Subsequent RT effectively eliminates common tumor cells. Results: Both in vitro cell experiments and in vivo animal studies demonstrate that SDT mediated by PMC synergistically enhances RT to selectively combat CSCs while inhibiting tumor growth without noticeable side effects. Discussion: Our findings offer novel insights for enhancing the efficacy and safety profiles of RT. Keywords: cancer stem cells clearance, radiosensitization, platelet membrane, sonodynamic therapy, manganese carbonate nanoparticles Although researchers have made remarkable progress in cancer biology, oncology and surgery in recent years, cancer remains one of the major diseases that lead to human death. 1,2 Among them, radiotherapy (RT) represents the predominant therapeutic approach, with approximately half of cancer patients opting for this modality either as a standalone treatment or in combination with other modalities to effectively manage cancer. 3 During RT, radiation ionization can generate free radicals, and then cause irreversible DNA damage. 4,5 Despite the widespread utilization of radiotherapy (RT) in cancer treatment, there persist several limitations. Due to the tumor's limited capacity for radiation absorption, high-intensity radiation is often required for effective tumor eradication, potentially leading to collateral damage in adjacent normal tissues. 6,7 Furthermore, the eradication of tumor cells is challenging in radiation therapy, and cancer recurrence and metastasis are the primary causes of death. 8 According to reports, cancer stem cells (CSCs) are closely related to the endless growth of tumors and the failure of RT. 9 CSCs are a small number of cells with infinite proliferation, self-renewal and multidirectional differentiation in tumor tissues. 10 The heterogeneity, special tumor microenvironment (TME), gene instability and flexible self-protection ability of CSCs can largely avoid the damage caused by RT. 11 CSCs can survive under high-dose radiation by regulating redox homeostasis, eliminating highly toxic ROS, repairing DNA damage and changing its division mode. Therefore, it is of great significance for cancer treatment to effectively eliminate differentiated cancer cells and potential CSCs. As most CSCs are located in the oxygen-deficient area of solid tumors, it is difficult for conventional nano-preparations and chemotherapy drugs to break through the physical barrier, resulting in limited killing effect on CSCs. 12 In recent years, the bionic technology of cell membrane camouflage nanoparticles has been attracting increasing attention. 13–15 Biomimetic nano-systems disguised by cell membrane have the advantages of excellent biocompatibility, prolonged blood circulation time and avoiding the immunity of the internal immune system. 16 This bionic camouflage technology not only accurately replicates the diverse antigens on the cell membrane surface (CD20, CD44, CD90, CD133, etc.), but also significantly simplifies the complex modification process of multifunctional nanoparticles. 17 Among them, platelet membrane-based biomimetic nanomaterials (PMN) based on platelet membrane can effectively target CD44 protein on the -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology